char = G;code = 71
Genetic modification through oligonucleotide-mediated mutagenesis. A GMO regulatory challenge?char = I;code = 73
Publication: Environ Biosafety Res 2009 Apr-Jun ;8(2)::57-64. :doi: 10.1051/ebr/2009007.
Publication Date: 2009 Apr-Jun
Study Author(s): Breyer, Didier;Herman, Philippe;Brandenburger, Annick;Gheysen, Godelieve;Remaut, Erik;Soumillion, Patrice;Van Doorsselaere, Jan;Custers, René;Pauwels, Katia;Sneyers, Myriam;Reheul, Dirk;
Institution: Scientific Institute of Public Health, Division of Biosafety and Biotechnology, Brussels, Belgium.
[email protected]
Shortcut link to this study:
In the European Union, the definition of a GMO is technology-based. This means that a novel organism will be regulated under the GMO regulatory framework only if it has been developed with the use of defined techniques. This approach is now challenged with the emergence of new techniques. In this paper, we describe regulatory and safety issues associated with the use of oligonucleotide-mediated mutagenesis to develop novel organisms. We present scientific arguments for not having organisms developed through this technique fall within the scope of the EU regulation on GMOs. We conclude that any political decision on this issue should be taken on the basis of a broad reflection at EU level, while avoiding discrepancies at international level.
How is this determined?
